Medicare Enrolled
Dr. Sandip Desai, MD
Optician · Sugar Land, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desai
Dr. Sandip Desai is an optician specialist in Sugar Land, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Desai performed 7,054 Medicare services across 3,731 unique beneficiaries.
Between the years covered by Open Payments, Dr. Desai received a total of $14,758 from 50 pharmaceutical and/or device companies across 768 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in TX
$14,758 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,054
Medicare services
Top 10% in TX for optician
3,731
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~353 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,237 | $91 | $300 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,154 | $92 | $301 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
754 | $0 | $3 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
633 | $61 | $200 |
| Inhaled albuterol and ipratropium bromide via DME Administration of FDA-approved albuterol and ipratropium bromide medication through durable medical equipment. |
356 | $0 | $1 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
337 | $40 | $125 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
329 | $7 | $55 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
328 | $28 | $180 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
325 | $42 | $125 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
304 | $163 | $681 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
290 | $10 | $50 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
278 | $132 | $549 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
224 | $4 | $15 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
163 | $82 | $301 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
115 | $116 | $450 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
90 | $136 | $400 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
38 | $26 | $100 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
23 | $79 | $400 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
21 | $20 | $100 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
19 | $22 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
19 | $30 | $60 |
| New patient office visit, complex (60-74 min) | 17 | $151 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,758
Total received (2018-2024)
Avg $2,108/year across 7 years
Top 13% in TX for optician
50
Companies
768
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,758 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,487
2023
$2,404
2022
$2,063
2021
$2,069
2020
$1,798
2019
$2,430
2018
$1,507
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,184
GlaxoSmithKline, LLC.
$2,397
Actelion Pharmaceuticals US, Inc.
$1,184
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,065
GENZYME CORPORATION
$1,012
Regeneron Healthcare Solutions, Inc.
$939
Electromed, Inc.
$688
Mylan Specialty L.P.
$575
Abbott Laboratories
$372
Genentech USA, Inc.
$294
United Therapeutics Corporation
$244
Sunovion Pharmaceuticals Inc.
$242
Amgen Inc.
$229
Mallinckrodt Hospital Products Inc.
$205
AbbVie Inc.
$178
Janssen Pharmaceuticals, Inc
$157
Teva Pharmaceuticals USA, Inc.
$151
Allergan Inc.
$147
Insmed, Inc.
$134
Edwards Lifesciences Corporation
$118
Novo Nordisk Inc
$103
BOSTON SCIENTIFIC CORPORATION
$103
Boston Scientific Corporation
$95
Philips Electronics North America Corporation
$91
Circassia Pharmaceuticals Inc
$66
Astellas Pharma US Inc
$63
Grifols USA, LLC
$62
Allergan, Inc.
$62
Shionogi Inc
$61
Merck Sharp & Dohme LLC
$55
Vanda Pharmaceuticals Inc.
$52
Mallinckrodt LLC
$50
Medtronic Vascular, Inc.
$48
PFIZER INC.
$30
Inogen, Inc.
$29
Gilead Sciences, Inc.
$25
Pulmonx Corporation
$24
MAYNE PHARMA INC.
$24
SANOFI-AVENTIS U.S. LLC
$24
Paratek Pharmaceuticals, Inc.
$23
Horizon Pharma plc
$23
ORGANOGENESIS INC.
$19
SANOFI US SERVICES INC.
$18
ANI Pharmaceuticals, Inc.
$17
Phadia US Inc.
$16
E.R. Squibb & Sons, L.L.C.
$14
Covis Pharma GmBH
$13
Harmony Biosciences LLC
$13
Exeltis, USA Inc.
$12
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 45.8% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · AirDuo Digihaler · Arikayce · Austedo XR · BREO · BREZTRI · BROVANA · CARDIOMEMS · CHARTIS CATHETER · CRESEMBA · DUAKLIR PRESSAIR · DUPIXENT · ELIQUIS · EMBLEM · EV1000 Clinical Platform · Esbriet · FASENRA · Fetroja · HETLIOZ · Hetlioz · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ImmunoCAP · InogenOne · JARDIANCE · LATUDA · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · Puraply · RAYOS · RESONATE · Reveal LINQ · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · Utibron · WINREVAIR · Wakix · Wegovy · XARELTO · Xembify · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $209 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
413
Per 100K population
48.0
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Desai is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), with low-engagement industry engagement in the top 13% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Desai experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Desai performed 1,237 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $14,758 from 50 companies across 768 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other opticians in Sugar Land?
Dr. Desai's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Sugar Land
Browse opticians in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology